What is Teriflunomide 7 mg?
Teriflunomide 7 mg is a prescription medication produced by MSN Laboratories, primarily used in the management of multiple sclerosis (MS). This drug contains the active ingredient Teriflunomide, a well-researched agent that helps reduce disease activity in patients living with MS.
Used worldwide, including Canada, Teriflunomide 7 mg offers a daily oral treatment option for individuals seeking effective management of their condition. Its safety profile and therapeutic effects have made it a valuable component in contemporary MS care.
Uses of Teriflunomide 7 mg
- Treatment of relapsing forms of multiple sclerosis
- Reduction of frequency of clinical exacerbations in MS patients
- Delay in the progression of physical disability caused by MS
How Teriflunomide 7 mg Works
Teriflunomide inhibits the function of rapidly dividing cells by targeting the enzyme dihydroorotate dehydrogenase (DHODH). By selectively suppressing activated T and B lymphocytes that contribute to the autoimmune response in MS, it reduces inflammation and nerve damage within the central nervous system.
This immunomodulatory action helps minimize disease flares and slows the evolution of neurological impairment, providing patients with improved long-term outcomes.
Benefits of Teriflunomide 7 mg
- Oral administration allows convenient once-daily dosing
- Effectively controls relapse rates in multiple sclerosis
- Helps delay progression of disability related to MS
- Manufactured under high-quality standards by MSN Laboratories
- Supports improved quality of life for MS patients
Dosage and Administration
The recommended dose of Teriflunomide 7 mg is one tablet taken orally once daily, with or without food. Consistent daily use at the prescribed dose is essential for optimal therapeutic effect. Patients should follow their healthcare provider’s instructions closely and never alter the dose without medical guidance.
Who Should Use Teriflunomide 7 mg?
Teriflunomide 7 mg is suitable for adults diagnosed with relapsing forms of multiple sclerosis. It is intended for patients seeking effective disease-modifying treatment to reduce relapse frequency and delay disability progression under medical supervision.
Who Should Avoid Teriflunomide 7 mg?
Individuals with known hypersensitivity to Teriflunomide or any other component of the tablet should avoid use. It is contraindicated in pregnant women, as it may cause harm to the fetus. Patients with severe liver impairment or active liver disease should not use this medication. Consultation with a healthcare professional is critical before starting treatment.
Side Effects
- Hair thinning or hair loss
- Nausea and vomiting
- Diarrhea
- Increased liver enzymes indicating potential liver irritation
- Headache
- Fatigue or tiredness
- Respiratory infections such as common colds
Safety Advice
- Regular liver function tests are recommended during treatment
- Avoid pregnancy during treatment and for an extended period after stopping the medication
- Inform your doctor if you have a history of liver problems or infections
- Use effective contraception while taking Teriflunomide 7 mg
- Consult your healthcare provider before starting new medicines or supplements
- Report any unusual symptoms or side effects promptly
Drug Interactions
- Immunosuppressive agents may increase the risk of infections
- Live vaccines should be avoided during treatment
- Drugs affecting liver function may alter Teriflunomide metabolism
- Cholestyramine or activated charcoal can reduce Teriflunomide levels in case of overdose
Storage Instructions
Store Teriflunomide 7 mg tablets in a cool, dry place away from direct sunlight. Keep the medication out of reach of children and do not use it beyond the expiry date stated on the packaging.
Where to buy Teriflunomide 7 mg in Canada?
Teriflunomide 7 mg can be obtained from licensed Canadian pharmacies with a valid prescription. Patients are advised to purchase from reputable sources to ensure authenticity and quality. Online Canadian pharmacies with appropriate certifications may offer safe and convenient purchasing options.
Frequently Asked Questions (FAQ)
Is Teriflunomide 7 mg available in Canada?
Yes, Teriflunomide 7 mg is available in Canada through authorized pharmacies with a prescription from a certified healthcare provider.
What is the price of Teriflunomide 7 mg in Canada?
Pricing varies depending on the pharmacy and insurance coverage. It is recommended to check with local pharmacies for the most accurate price information.
What happens if I miss a dose?
If a dose is missed, take it as soon as remembered unless it is almost time for the next dose. Do not double up doses. Consult your healthcare provider for guidance if uncertain.
Where can I find Teriflunomide 7 mg for sale?
Teriflunomide 7 mg is sold at licensed pharmacies in Canada. Some verified online pharmacies also provide access with a valid prescription.
Can Teriflunomide 7 mg be used during pregnancy?
No, Teriflunomide 7 mg is not recommended during pregnancy due to potential risks to the fetus. Effective contraception is advised during treatment.
How long does it take to see the effects of Teriflunomide 7 mg?
Therapeutic effects may be noticeable after several weeks of continuous treatment. However, individual responses vary, and ongoing medical evaluation is important.
Are there any foods or medications to avoid while taking Teriflunomide 7 mg?
Avoid live vaccines and discuss all medications and supplements with your healthcare provider to prevent interactions.
Conclusion
Teriflunomide 7 mg by MSN Laboratories is an effective oral treatment option for managing relapsing multiple sclerosis. Its targeted action helps reduce relapse rates and slow disability progression, improving patient quality of life. When used as prescribed and under medical supervision, Teriflunomide 7 mg offers a reliable addition to comprehensive MS therapy in Canada.
Leave A Review